Michael Pulsipher Joins Children’s Hospital Los Angeles
The renowned researcher will head the Blood and Marrow Transplantation (BMT) section at CHLA, one of world’s largest pediatric BMT programs
LOS ANGELES (June 30, 2015)--Michael Allen Pulsipher, MD, will join the Children’s Center for Cancer and Blood Diseases and the Division of Hematology, Oncology and Blood and Marrow Transplantation at Children’s Hospital Los Angeles as head of the Section of Blood and Marrow Transplantation (BMT) and as BMT clinical research chair, effective July 1, 2015. In addition, Pulsipher will be a professor of Pediatrics at the Keck School of Medicine of the University of Southern California (USC) and a Member of the USC Norris Comprehensive Cancer Center.
The pediatric BMT Program at CHLA is one of the largest in the world, having performed more than 1,300 transplants since 1983 for a wide variety of pediatric disorders including malignant, hematological, immunodeficiency and other diseases. In directing the pediatric BMT program’s clinical care and clinical research activities, Pulsipher will closely collaborate in the further development of a leading research program that integrates laboratory and clinical science toward the delivery of innovative cell-based therapies.
“Children’s Hospital Los Angeles is very excited to have Dr. Pulsipher join us in this important leadership position, as we work to develop more effective and less toxic therapies for children with cancer and blood diseases,” said Alan Wayne, MD, Director of the Children's Center for Cancer and Blood Diseases and Division Head of Hematology, Oncology and Blood and Marrow Transplantation at CHLA. “In addition to providing overall direction for our transplantation program, his research expertise will bring additional strength to our team of clinicians and scientists at CHLA who are leading the fight against refractory childhood leukemia.”
Pulsipher most recently served at Primary Children’s Hospital and the University of Utah School of Medicine in Salt Lake City. He earned his medical degree at Stanford University School of Medicine, followed by residency training in pediatrics at Children’s Hospital of Philadelphia and pediatric hematology-oncology fellowship training at Boston Children’s Hospital/Dana-Farber Cancer Institute. Among his many leadership roles, Pulsipher has served as director of the Utah Blood and Marrow Transplant Program, as medical director of the Utah Cord Blood Program, and as current group chair of the Pediatric Blood and Marrow Transplant Consortium – an 80-member international clinical trials group, recognized as a leading influence in the field of pediatric BMT.
Pulsipher is a highly accomplished NIH-funded investigator whose major areas of research focus in BMT include innovative approaches for children with acute lymphoblastic leukemia and bone marrow failure conditions, reduced toxicity regimens and donor safety. He is currently principal or co-principal investigator on six national, multi-center studies and a co-investigator on multiple additional clinical trials. Dr. Pulsipher has authored more than 130 articles in peer-reviewed journals including Journal of Clinical Investigation, Blood, and Nature Genetics. He has also written five book chapters and presented widely at national and international conferences.
Board-certified by the American Board of Pediatrics and its Sub-board of Pediatric Hematology-Oncology, he is a Specialty Fellow of the American Academy of Pediatrics and a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Society of Pediatric Hematology/Oncology, the American Society of Blood and Marrow Transplantation, and the World Marrow Donor Association. He serves on the editorial boards of Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, and Pediatric Blood and Cancer. He is also a member of the National Cancer Institute’s Pediatric Data Query Editorial Board.
About Children’s Hospital Los Angeles
Children's Hospital Los Angeles has been named the best children’s hospital in California and among the top 10 in the nation for clinical excellence with its selection to the prestigious U.S. News & World Report Honor Roll. Children’s Hospital is home to The Saban Research Institute, one of the largest and most productive pediatric research facilities in the United States. Children’s Hospital is also one of America's premier teaching hospitals through its affiliation since 1932 with the Keck School of Medicine of the University of Southern California. For more information, visit CHLA.org. Follow us on Twitter, Facebook, YouTube and LinkedIn, or visit our blog at http://researchlablog.org/.